Jpmorgan Chase & CO Maia Biotechnology, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 42 shares of MAIA stock, worth $63. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42
Previous 45
6.67%
Holding current value
$63
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MAIA
# of Institutions
22Shares Held
2.26MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.14MShares$1.73 Million0.0% of portfolio
-
Centric Wealth Management573KShares$871,5640.26% of portfolio
-
Geode Capital Management, LLC Boston, MA222KShares$337,7180.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$119,3510.0% of portfolio
-
State Street Corp Boston, MA75.6KShares$114,8360.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $16.6M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...